Join to View Full Profile
10735 Lindbrook DrLos Angeles, CA 90024
Phone+1 310-801-7123
Dr. Gaut is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
David Geffen School of Medicine at UCLAClass of 2017
Certifications & Licensure
CA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.Caspian Oliai, Sunmin Park, Lloyd E Damon, Brian A Jonas, Deepa Jeyakumar
Leukemia & Lymphoma. 2025-04-01 - 2 citationsMeasurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.Daria Gaut, Caspian Oliai, Jonathan Boiarsky, Shiliang Zhang, Amandeep Salhotra
Leukemia & Lymphoma. 2024-01-01 - Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of Californ...Tamer Othman, Michelle A Quan, Shiliang Zhang, Daria Gaut, Patricia A Young
Clinical Lymphoma, Myeloma & Leukemia. 2023-10-01
Abstracts/Posters
- Granulocyte Colony-Stimulating Factor (G-CSF) Interactions with Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell LymphomaDaria Gaut, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Outcomes Related to Intravenous Fluid Administration in Sickle Cell Patients during Vaso-Occlusive Crisis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Disease characteristics of diffuse large B-cell lymphoma predicting relapse after autologous stem cell transplantation.2019 ASCO Annual Meeting - 6/1/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
